FDA Approves Tildrakizumab for Psoriatic Arthritis Treatment

The FDA has approved tildrakizumab for psoriatic arthritis treatment, expanding its use beyond plaque psoriasis.

Clinicians increasingly rely on non-federal health guidance as trust in federal agencies declines, seeking evidence-based resources.

AI in healthcare risks widening disparities without stronger ethics, as experts warn marginalized groups face greater dangers than…

On October 20, the FDA cleared bepirovirsen, marketed as Hibsago, for use in adults battling chronic hepatitis B…

Methadone remains a cornerstone for opioid use disorder, yet the rise of illicit fentanyl has altered the patient…

Doctors diagnose metabolic dysfunction-associated steatohepatitis (MASH) through blood tests and imaging, and explore emerging treatment options fo

New research shows large language models may uncover hidden dimensions in chronic pain assessment that traditional severity scales…

New medical codes take effect January 1, including updates to maternity care and speech therapy codes, one of…

Physicians encouraged to adopt failure as a learning tool to improve healthcare excellence.

Alzheimer's group aims to improve brain care through standardizing dementia treatment and care pathways.